HRP20211151T1 - Kristalinska tosilatna sol pi3k delta selektivnog inhibitora za uporabu u farmaceutskim formulacijama - Google Patents
Kristalinska tosilatna sol pi3k delta selektivnog inhibitora za uporabu u farmaceutskim formulacijama Download PDFInfo
- Publication number
- HRP20211151T1 HRP20211151T1 HRP20211151TT HRP20211151T HRP20211151T1 HR P20211151 T1 HRP20211151 T1 HR P20211151T1 HR P20211151T T HRP20211151T T HR P20211151TT HR P20211151 T HRP20211151 T HR P20211151T HR P20211151 T1 HRP20211151 T1 HR P20211151T1
- Authority
- HR
- Croatia
- Prior art keywords
- disease
- cancer
- salt
- disorder
- autoimmune
- Prior art date
Links
- 229940124639 Selective inhibitor Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000005490 tosylate group Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 206010052779 Transplant rejections Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 3
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 claims 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 2
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 2
- 108091007960 PI3Ks Proteins 0.000 claims 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 206010047115 Vasculitis Diseases 0.000 claims 2
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 201000001981 dermatomyositis Diseases 0.000 claims 2
- 201000005787 hematologic cancer Diseases 0.000 claims 2
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 2
- 208000006454 hepatitis Diseases 0.000 claims 2
- 231100000283 hepatitis Toxicity 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 208000019423 liver disease Diseases 0.000 claims 2
- 206010025135 lupus erythematosus Diseases 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000003343 Antiphospholipid Syndrome Diseases 0.000 claims 1
- 206010003571 Astrocytoma Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000030767 Autoimmune encephalitis Diseases 0.000 claims 1
- 206010003827 Autoimmune hepatitis Diseases 0.000 claims 1
- 208000015338 Autoimmune hepatitis type 1 Diseases 0.000 claims 1
- 208000003950 B-cell lymphoma Diseases 0.000 claims 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 1
- 208000023514 Barrett esophagus Diseases 0.000 claims 1
- 208000009137 Behcet syndrome Diseases 0.000 claims 1
- 206010004593 Bile duct cancer Diseases 0.000 claims 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 208000006386 Bone Resorption Diseases 0.000 claims 1
- 208000020084 Bone disease Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000031229 Cardiomyopathies Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 208000016192 Demyelinating disease Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010012468 Dermatitis herpetiformis Diseases 0.000 claims 1
- 206010014612 Encephalitis viral Diseases 0.000 claims 1
- 208000010334 End Stage Liver Disease Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 201000008808 Fibrosarcoma Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 208000004463 Follicular Adenocarcinoma Diseases 0.000 claims 1
- 208000007465 Giant cell arteritis Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 206010072579 Granulomatosis with polyangiitis Diseases 0.000 claims 1
- 208000003807 Graves Disease Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 208000003923 Hereditary Corneal Dystrophies Diseases 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 208000005615 Interstitial Cystitis Diseases 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010024229 Leprosy Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 201000009906 Meningitis Diseases 0.000 claims 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims 1
- 201000002481 Myositis Diseases 0.000 claims 1
- 206010029164 Nephrotic syndrome Diseases 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 241000243985 Onchocerca volvulus Species 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 201000011152 Pemphigus Diseases 0.000 claims 1
- 208000031845 Pernicious anaemia Diseases 0.000 claims 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 201000010208 Seminoma Diseases 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 206010058141 Skin graft rejection Diseases 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 206010042742 Sympathetic ophthalmia Diseases 0.000 claims 1
- 206010042971 T-cell lymphoma Diseases 0.000 claims 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 206010046914 Vaginal infection Diseases 0.000 claims 1
- 201000008100 Vaginitis Diseases 0.000 claims 1
- 206010047112 Vasculitides Diseases 0.000 claims 1
- 206010047642 Vitiligo Diseases 0.000 claims 1
- 210000004100 adrenal gland Anatomy 0.000 claims 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
- 229940035676 analgesics Drugs 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229940125715 antihistaminic agent Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 208000006424 autoimmune oophoritis Diseases 0.000 claims 1
- 201000004982 autoimmune uveitis Diseases 0.000 claims 1
- 208000026900 bile duct neoplasm Diseases 0.000 claims 1
- 230000024279 bone resorption Effects 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000006990 cholangiocarcinoma Diseases 0.000 claims 1
- 208000011444 chronic liver failure Diseases 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 206010011005 corneal dystrophy Diseases 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 201000002491 encephalomyelitis Diseases 0.000 claims 1
- 206010014801 endophthalmitis Diseases 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 208000007565 gingivitis Diseases 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 208000009326 ileitis Diseases 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 229960003444 immunosuppressant agent Drugs 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 claims 1
- 208000013256 infectious meningitis Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 208000025113 myeloid leukemia Diseases 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- 208000009928 nephrosis Diseases 0.000 claims 1
- 231100001027 nephrosis Toxicity 0.000 claims 1
- 210000000653 nervous system Anatomy 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 208000002042 onchocerciasis Diseases 0.000 claims 1
- 201000005737 orchitis Diseases 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 201000008968 osteosarcoma Diseases 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
- -1 p-toluenesulfonic acid compound Chemical class 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 201000001976 pemphigus vulgaris Diseases 0.000 claims 1
- 201000001245 periodontitis Diseases 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000005987 polymyositis Diseases 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 201000011461 pre-eclampsia Diseases 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 206010043207 temporal arteritis Diseases 0.000 claims 1
- 208000001608 teratocarcinoma Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 206010043554 thrombocytopenia Diseases 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 208000030901 thyroid gland follicular carcinoma Diseases 0.000 claims 1
- 206010043778 thyroiditis Diseases 0.000 claims 1
- 206010044325 trachoma Diseases 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 201000008827 tuberculosis Diseases 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 201000002498 viral encephalitis Diseases 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (9)
1. Kristalna sol spoja p-toluensulfonske kiseline
[image]
pri čemu sol pokazuje XRPD uzorak koji ima jedan ili više vrhova odabranih između 5.0, 10.1, 22.1 i 24.5 + 0.2 ° 2Θ, mjereno na X’PertPRO MPD difraktometru opremljenom Cu CFF rendgenskom cijevi; i pri čemu kristalna sol ima raspodjelu veličine čestica d (0.9) od 5 do 50 µm.
2. Sol prema zahtjevu 1, naznačena time, da sol ima d (0.5) od 1 do 10 µm.
3. Sol prema zahtjevu 1 ili zahtjevu 2, naznačena time da sol ima d (0.5) od 2 do 5 µm.
4. Sol prema bilo kojem od zahtjeva 1 do 3, naznačena time, da sol ima d (0.9) od 5 do 25 µm ili 5 do 15 µm.
5. Sol prema bilo kojem od zahtjeva 1 do 4, naznačena time, da sol ima d (0.1) od 0.5 do 1.5 µm ili 0.5 do 1.0 µm.
6. Sol prema bilo kojem od zahtjeva 1 do 5, naznačena time da sol pokazuje uzorak diferencijalnog skenirajućeg kalorimetra (DSC) s karakterističnim endotermnim vrhom na 146 ° C.
7. Farmaceutski pripravak, naznačen time, da sadrži sol prema bilo kojem od prethodnih zahtjeva i farmaceutski prihvatljiv ekscipijens.
8. Farmaceutski pripravak prema zahtjevu 7, naznačen time, da nadalje sadrži jedno ili više dodatnih terapijskih sredstava odabranih između sredstava protiv raka, protuupalnih sredstava, imunosupresiva, steroida, nesteroidnih protuupalnih sredstava, antihistaminika, analgetika i njihovih smjesa.
9. Sol prema bilo kojem od zahtjeva 1 do 6, naznačena time, da se koristi u liječenju bolesti ili poremećaja povezanih s PI3K, naznačena time što je bolest, poremećaj ili stanje povezano s PI3K bolest povezana s imunološkim sustavom, bolest ili poremećaj koji uključuje upalu, rak ili druge proliferativne bolesti, jetrenu bolest ili poremećaj ili bubrežnu bolest ili poremećaj i odabrani su između krvotvornih tumora limfoidne loze, leukemije, akutne limfocitne leukemije, akutne limfoblastne leukemije, B-staničnog limfoma, T-staničnog limfoma, Hodgkinovog limfoma, non-Hodgkinsova limfoma, limfoma dlakavih stanica i Burkettova limfoma; hematopoetskih tumora mijeloidne loze, akutne mijelogene leukemije, kronične mijelogene leukemije, mijelodisplastičnog sindroma, mijelocitne leukemije; karcinoma mokraćnog mjehura, karcinoma dojke, karcinoma debelog crijeva, karcinoma bubrega, karcinoma jetre, karcinoma pluća, karcinoma malih stanica pluća, karcinoma jednjaka, karcinoma žuči, raka jajnika, karcinoma gušterače, raka želuca, raka vrata maternice, raka štitnjače, raka prostate, raka kože, karcinoma skvamoznih stanica; tumori mezenhimskog porijekla, fibrosarkoma, rabdomiosarkoma; tumora središnjeg i perifernog živčanog sustava, astrocitoma, neuroblastoma, glioma, svannoma; melanoma, seminoma, teratokarcinoma, osteosarkoma, ksenoderoma pigmentosum, keratoktantoma, folikularni karcinom štitnjače, Kaposijev sarkom, upala, glomerulonefritis, uveitis, jetrene bolesti ili poremećaji, bubrežne bolesti ili poremećaji, kronična opstruktivna plućna bolest, reumatoidni artritis, upalni dermatitis, osteoartritis, upalna bolest mišića, alergijski rinitis, vaginitis, intersticijski cistitis, skleroderma, osteoporoza, ekcem, alogena ili ksenogena transplantacija, odbacivanje transplantata, bolest transplantata protiv domaćina, eritematozni lupus, plućna fibroza, dermatomiozitis, tiroiditis, mijasthezija autoimuna hemolitička anemija, cistična fibroza, kronični recidivirajući hepatitis, primarna bilijarna ciroza, alergijski konjunktivitis, hepatitis, atopijski dermatitis, astma, Sjogrenov sindrom, odbacivanje transplantata organa, multipla skleroza, Guillain-Barre, autoimuni uveitis, autoimuna hemolitička anemija, perniciozna anemija trombocitopenija, temporalni arteritis, antifosfolipidni sindrom, vaskulitidi poput Wegenerove granulomatoze, Behcetove bolesti, psorijaze, dermatitisa herpetiformisa, vulgarnog pemfigusa, vitiliga, Crohnove bolesti, kolitisa, ulceroznog kolitisa, primarne bilijarne imunološke ciroze, autoimunog hepatitisa tipa 1, autoimunog hepatitisa dijabetes melitus, Graveova bolest, Hashimotov tireoiditis, autoimuni ooforitis i orhitis, autoimuni poremećaj nadbubrežne žlijezde, sistemski eritematozni lupus, polimiozitis, dermatomiozitis, ankilozirajući spondilitis, odbacivanje transplantata, odbacivanje transplantata kože, artritis, bolesti kostiju povezane s povećanom resorpcijom kostiju ; ileitis, Barrettov sindrom, respiratorni distres sindrom odrasle osobe, kronična opstruktivna bolest dišnih putova; distrofija rožnice, trahom, onhocercijaza, simpatički oftalmitis, endoftalmitis; gingivitis, parodontitis; tuberkuloza; guba; uremičke komplikacije, nefroza; sklerodermatitis, psorijaza, kronične demijelinizirajuće bolesti živčanog sustava, neurodegeneracija povezana sa AIDS-om, Alzheimerova bolest, zarazni meningitis, encefalomijelitis, Parkinsonova bolest, Huntingtonova bolest, amiotrofična lateralna skleroza virusni ili autoimuni encefalitis; autoimuni poremećaji, vaskulitis imunog kompleksa, sistemski lupus i eritematode; sistemski eritemski lupus (SLE); kardiomiopatija, ishemijska bolest srca hiperkolesterolemija, ateroskleroza, preeklampsija; kronično zatajenje jetre, trauma mozga i leđne moždine i rak.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2597CH2014 | 2014-05-27 | ||
IN2596CH2014 | 2014-05-27 | ||
PCT/IB2015/053940 WO2015181728A1 (en) | 2014-05-27 | 2015-05-26 | Improved forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations |
EP15733532.4A EP3149000B1 (en) | 2014-05-27 | 2015-05-26 | Crystalline tosylate salt of a pi3k delta selective inhibitor for use in pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20211151T1 true HRP20211151T1 (hr) | 2021-10-15 |
Family
ID=53499042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20211151TT HRP20211151T1 (hr) | 2014-05-27 | 2021-07-19 | Kristalinska tosilatna sol pi3k delta selektivnog inhibitora za uporabu u farmaceutskim formulacijama |
Country Status (21)
Country | Link |
---|---|
US (4) | US9969740B2 (hr) |
EP (2) | EP3149000B1 (hr) |
JP (3) | JP6987501B2 (hr) |
KR (1) | KR20170007480A (hr) |
CN (2) | CN106661030B (hr) |
AU (1) | AU2015265542B2 (hr) |
BR (1) | BR112016027674A2 (hr) |
CA (1) | CA2949932C (hr) |
CY (1) | CY1124316T1 (hr) |
DK (1) | DK3149000T3 (hr) |
EA (1) | EA032506B1 (hr) |
ES (1) | ES2880999T3 (hr) |
HR (1) | HRP20211151T1 (hr) |
HU (1) | HUE054916T2 (hr) |
IL (1) | IL249058B2 (hr) |
LT (1) | LT3149000T (hr) |
PL (1) | PL3149000T3 (hr) |
PT (1) | PT3149000T (hr) |
RS (1) | RS62136B1 (hr) |
SI (1) | SI3149000T1 (hr) |
WO (1) | WO2015181728A1 (hr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI3149000T1 (sl) * | 2014-05-27 | 2021-09-30 | Rhizen Pharmaceuticals S.A. | Kristalinična tosilatna sol selektivnega inhibitorja PI3K delta za uporabo v farmacevtskih oblikah |
EA201892284A1 (ru) | 2016-05-27 | 2019-08-30 | Тг Терапьютикс, Инк. | Комбинация антитела против cd20, селективного ингибитора pi3-киназы-дельта и ингибитора btk для лечения b-клеточных пролиферативных расстройств |
BR112019004185A2 (pt) | 2016-09-09 | 2019-09-03 | Lab Francais Du Fractionnement | combinação de um anticorpo anti-cd20, inibidor de pi3-quinase-delta inibidor e anticorpo anti-pd-1 ou anti-pd-l1 para tratamento de cânceres hematológicos |
JP2022540466A (ja) | 2019-07-15 | 2022-09-15 | ジョンソン、マッセイ、パブリック、リミテッド、カンパニー | 非晶質ウムブラリシブモノトシレート |
US20220143026A1 (en) | 2020-11-12 | 2022-05-12 | Tg Therapeutics, Inc. | Triple combination to treat b-cell malignancies |
US11814439B1 (en) | 2022-06-01 | 2023-11-14 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
US11884740B1 (en) | 2022-06-01 | 2024-01-30 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
US11807689B1 (en) | 2022-06-01 | 2023-11-07 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
US11965032B1 (en) | 2022-06-01 | 2024-04-23 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1939203E (pt) * | 2000-04-25 | 2015-02-04 | Icos Corp | Inibidores da isoforma delta da fosfatidil-inositol 3-quinase humana |
TWI335821B (en) | 2002-12-16 | 2011-01-11 | Genentech Inc | Immunoglobulin variants and uses thereof |
WO2005016348A1 (en) | 2003-08-14 | 2005-02-24 | Icos Corporation | Method of inhibiting immune responses stimulated by an endogenous factor |
CN104042618B (zh) | 2008-11-13 | 2018-02-16 | 吉利德卡利斯托加公司 | 恶性血液病的治疗 |
AU2010229968A1 (en) | 2009-03-24 | 2011-10-13 | Gilead Calistoga Llc | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
EA201101507A1 (ru) | 2009-04-20 | 2012-05-30 | Гилеад Калистога Ллс. | Способы лечения солидных опухолей |
SI2870157T1 (en) * | 2012-07-04 | 2018-02-28 | Rhizen Pharmaceuticals S.A. | SELECTIVE PI3K-DELTA INHIBITORS |
SI3149000T1 (sl) * | 2014-05-27 | 2021-09-30 | Rhizen Pharmaceuticals S.A. | Kristalinična tosilatna sol selektivnega inhibitorja PI3K delta za uporabo v farmacevtskih oblikah |
-
2015
- 2015-05-26 SI SI201531656T patent/SI3149000T1/sl unknown
- 2015-05-26 CN CN201580034288.7A patent/CN106661030B/zh active Active
- 2015-05-26 EP EP15733532.4A patent/EP3149000B1/en active Active
- 2015-05-26 KR KR1020167036318A patent/KR20170007480A/ko not_active Application Discontinuation
- 2015-05-26 AU AU2015265542A patent/AU2015265542B2/en active Active
- 2015-05-26 ES ES15733532T patent/ES2880999T3/es active Active
- 2015-05-26 PL PL15733532T patent/PL3149000T3/pl unknown
- 2015-05-26 HU HUE15733532A patent/HUE054916T2/hu unknown
- 2015-05-26 EP EP21182208.5A patent/EP3971188A1/en not_active Withdrawn
- 2015-05-26 EA EA201692255A patent/EA032506B1/ru unknown
- 2015-05-26 LT LTEPPCT/IB2015/053940T patent/LT3149000T/lt unknown
- 2015-05-26 RS RS20210920A patent/RS62136B1/sr unknown
- 2015-05-26 WO PCT/IB2015/053940 patent/WO2015181728A1/en active Application Filing
- 2015-05-26 US US15/313,454 patent/US9969740B2/en active Active
- 2015-05-26 JP JP2016569636A patent/JP6987501B2/ja active Active
- 2015-05-26 PT PT157335324T patent/PT3149000T/pt unknown
- 2015-05-26 CA CA2949932A patent/CA2949932C/en active Active
- 2015-05-26 DK DK15733532.4T patent/DK3149000T3/da active
- 2015-05-26 BR BR112016027674A patent/BR112016027674A2/pt not_active Application Discontinuation
- 2015-05-26 CN CN202010471226.5A patent/CN111635406A/zh active Pending
-
2016
- 2016-11-20 IL IL249058A patent/IL249058B2/en unknown
-
2018
- 2018-04-11 US US15/950,606 patent/US10414773B2/en active Active
-
2019
- 2019-08-30 US US16/557,091 patent/US10947244B2/en active Active
-
2020
- 2020-05-20 JP JP2020088147A patent/JP2020122022A/ja active Pending
- 2020-12-23 US US17/247,806 patent/US20210269446A1/en not_active Abandoned
-
2021
- 2021-07-19 HR HRP20211151TT patent/HRP20211151T1/hr unknown
- 2021-07-21 CY CY20211100652T patent/CY1124316T1/el unknown
-
2022
- 2022-04-05 JP JP2022062937A patent/JP2022082680A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20211151T1 (hr) | Kristalinska tosilatna sol pi3k delta selektivnog inhibitora za uporabu u farmaceutskim formulacijama | |
HRP20171610T1 (hr) | Selektivni inhibitori pi3k delta | |
JP2019163290A5 (hr) | ||
JP2017516785A5 (hr) | ||
JP2017505808A5 (hr) | ||
JP2019519598A5 (hr) | ||
RU2014121073A (ru) | Бициклические соединения пиперазина | |
JP2019515043A5 (hr) | ||
JP2016523973A5 (hr) | ||
JP2020537657A5 (hr) | ||
JP2010509342A5 (hr) | ||
JP2012504605A5 (hr) | ||
HRP20210086T1 (hr) | Kristalni metiltioninij-klorid-hidrati | |
JP2011526244A5 (hr) | ||
HRP20160208T4 (hr) | Polimorfi dasatiniba i postupak za njihovu pripremu | |
JP2017504650A5 (hr) | ||
JP2016537346A5 (hr) | ||
JP2010535218A5 (hr) | ||
JP2013510133A5 (hr) | ||
JP2012504603A5 (hr) | ||
JP2010535215A5 (hr) | ||
RU2007102576A (ru) | Новые индаэолкарбоксамиды и их применение | |
JP2015516968A5 (hr) | ||
JP2018520147A5 (hr) | ||
JP2020506244A5 (hr) |